Eprotirome Terminated Phase 3 Trials for Heterozygous Familial Hypercholesterolemia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT01410383Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care